Abstract:There is increasing data showing that angiotensin (Ang) II may be involve in the initiation and regulation of processes occurring in brain ischemia. Microvascular changes in the brain are notably the cause of cerebral edema and ischemia injury. we have recently shown Ang II injuries brain microvascular endothelial cells (BMECs) partly via regulation of intercellular adhesion molecule-1 (ICAM-1) expression. However, the signaling cascade leading to Ang II-induced ICAM-1 expression in BMECs had not been well elucidated. The transcription factor, nuclear factor-κB (NF-κB) is involved in the expression of several proinflammatory genes including cell adhesion molecules. The aim of the present study was to investigate the possible mechanism of Ang II regulating the expression of ICAM-1 in BMECs and evaluated the effect of a novel selective AT1 receptor antagonist EXP-2528. Cultured BCMECs were incubated with Ang II (10-7 mol/L) with or without the specific AT1 receptor inhibitor losartan (10-6 mol/L) and EXP-2528 (10-6 mol/L) and the specific AT2 receptor inhibitor PD 123,319 (10-6 mol/L) for indicated times. Total RNA, cytoplasmic and nuclear protein were extracted from different groups of cultured BMECs. RT-PCR was used to assess ICAM-1 mRNA expression, western blot analysis was used to assess ICAM-1 and IκBα protein expression. Nuclear extracts were used for western blot analysis of p65 protein expression and for electrophoretic mobility shift assay of NF-κB activity. Ang II directly stimulates ICAM-1 mRNA and protein expression in BMECs. Ang II treatment also resulted in the degradation of IκBα, an evident increasing of p65 subunit expression in the nucleus as well as the nuclear translocation of NF-κB. These effects were abolished by preincubation with the AT1-specific antagonist losartan or EXP-2528 or losartan plus the AT2 receptor antagonist PD123319 but not by PD123319 alone. Moreover, there were no significant difference between losartan group and losartan + PD 123,319 group. The present study demonstrates that Ang II upregulated ICAM-1 expression via NF-κB activation in BMECs by activating AT1 receptor, AT1 receptor antagonists, both EXP-2528 and losartan inhibit such effect of Ang II.

Angiopoietin-1 Regulating the Inflammatory Factors of Endothelial Progenitor Cells Through Nuclear Factor-kappa B Signaling Pathway

The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ

Effects of angiopoietin-1 on inflammatory injury in endothelial progenitor cells and blood vessels.

[Effects of Angiotensin II on Peripheral Blood Endothelial Progenitor Cells].

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Inhibition of Microvascular Endothelial Cell Apoptosis by Angiopoietin-1 and the Involvement of Cytochrome C.

Experimental Study of Peripheral Blood Derived Endothelial Progenitor Cells Transfected with Ang-1 Gene

Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway

Pim Protein Kinase-3 is Regulated by TNF-α and Promotes Endothelial Cell Sprouting

Modulation of the number and functions of endothelial progenitor cells by interleukin 1β in the peripheral blood of pigs: involvement of p38 mitogen-activated protein kinase signaling in vitro.

EXP-2528, a Novel Angiotensin II Type 1 Receptor Antagonist, Protects Angiotensin II-stimulated Intercellular Adhesion Molecule-1 Via Nuclear Factor-Κb Activation in Brain Microvascular Endothelial Cells

Study on the angiogenesis of human umbilical cord blood endothelial progenitor cells mediated by Fn14-PI3K-Akt-induced TWEAK

Angiopoietin-1/Tie2 signaling pathway inhibits lipopolysaccharide-induced activation of RAW264.7 macrophage cells.

Erythropoietin Activates Autophagy to Regulate Apoptosis and Angiogenesis of Periodontal Ligament Stem Cells via the Akt/ERK1/2/BAD Signaling Pathway under Inflammatory Microenvironment

Abstract 501: Angiotensin II Increases Angiogenesis by Nf-κB-mediated Transcriptional Activation of Angiogenic Factor Aggf1

Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Tumor Necrosis Factor-Α-induced Apoptosis in Endothelial Colony-Forming Cells

Transcription Factor Ap-1 Mediates Proangiogenic MIF Expression in Human Endothelial Cells Exposed to Angiotensin II

Genetically modified endothelial progenitor cells with hNotch1. ICN overexpression display facilitated angiogenesis

Cartilage Oligomeric Matrix Protein-Angiopoietin-1 Has a Protective Effect of Vascular Endothelial Barrier in Rat with Acute Necrotizing Pancreatitis

Angiogenesis by hypoxia inducible factor-1α transfected endothelial progenitor cells

Angiogenic Factor With G Patch And Fha Domains 1 Is A Novel Regulator Of Vascular Injury